Series of novel artemisinin derivatives were designed and synthesized in which the amino propanol group was bonded to the artemisinin nucleus through C-C linkage. Ten new compounds were thus successfully prepared and evaluated as cytotoxic agents, revealing an interesting anticancer activity in KB and HepG2 cancer cell lines.
Artemisinin (1), a sesquiterpene lactone endoperoxide, isolated from Artemisia annua L, and its derivatives (such as dihydroartemisinin, artesunate, arteether) have been used as important lead compounds for antimalaria drug development [1] [2] [3] . In addition to their well-known antimalarial activity, artemisinin derivatives have received much attention in the search for new anticancer agents due to the similar mechanisms underlying both antitumor and antimalarial properties [4] [5] . A number of artemisinin derivatives showed highly potent cytotoxicity against several cancer cell lines [6] [7] [8] , antiviral [9] , and immunosuppressive properties [10] . Besides that, functionalized β-aminopropanols are not only part of biologically active agents [11] [12] [13] [14] , but also important intermediates or precursors in the chemical synthesis of therapeutically or biologically relevant compounds [15] . The introduction of β-aminopropanol into C-10 side chain of artemisinin led to a new type of water soluble artemisinin derivatives 2 ( Fig. 1) , that showed antimalarial activity and other bioactivities such as local anesthetics [14] . In our previous study, the enantiomerically pure artemisinin derivatives 3 containing an amino alcohol group were isolated separately and exhibited high antimalarial active with IC 50 values below 5 ng/mL [13] . These biological results clearly indicated the importance of aminopropanol groups to the antimalarial activity of artemisinin derivatives. In this study, we reported the synthesis and cytotoxic activity of several artemisinin derivatives, in which the amino propanol group is bonded to the artemisinin nucleus through C-C linkage. 
.
Scheme 1:
Synthetic route of compounds 7a-j.
For this purpose, 10-deoxoartemisinins containing aminopropanol group7a-j were obtained via the synthetic procedure shown in Scheme 1. The key intermediate compound 5 was prepared by the treatment of 10α-acetyldihydroartemisinin 4 with allyltrimethylsilane in the presence of zinc chloride [16] . Epoxidation of compound 5 using m-CPBA afforded a mixture of two isomers 6 [16] . The latters were then reacted with amine to give the aminopropanols 7a-j in 60-70% yields. The chemical structure of synthesized compounds 7a-j was determined by 1 H NMR, 13 C NMR, IR and LC-MS/MS spectra. According to the 1 H NMR spectroscopy, the configuration at C-10 of these compounds were assigned based on the vicinal couplings, 3 J 9,10 , which is generally All the synthesized compounds 7a-j were then subjected to in vitro biological assessment against two human cancer cell lines (KB and HepG2) in order to evaluate their potential as cytotoxic agents, and the results are summarized in Table 1 . Ellipticine and dihydroartemisinin were used as positive controls. The results indicated that most of these derivatives possess at least moderate cytotoxic activity. In particular, compounds 7f and 7g showed good inhibitory activity against both cell lines, comparing to the parent dihydroartemisinin (DHA), pointing to the potential interest in this new class of hybrid molecules. Especially, compound 7f displayed the most potent inhibitory activity against KB, and HepG2 with IC 50 -values of 18.2 µM and 27.5 µM, respectively, which was up to 5 fold higher than those of DHA. In conclusion, ten new artemisinin derivatives containing an aminopropanol group were successfully prepared as cytotoxic agents. The biological results clearly demonstrated the added value of merging dihydroxyartemisinin with aminopropanol into single hybrid compounds through a C-C linkage in terms of their anticancer activities.
Experimental
General: All reactions were performed in the appropriate ovendried glass apparatus and under air atmosphere. Unless otherwise stated, solvents and chemicals were obtained from commercial sources and used without further purification. Flash column chromatography was performed using silica gel (60Å, particle size 40-60 µm). TLC analysis was performed on precoated silica gel GF254-slides, and visualized by either UV irradiation or Ce(SO 4 ) 2 staining. 1 H NMR spectra were recorded on a Bruker Avance (500 MHz) with samples dissolved in CDCl 3 and data are reported in ppm with the solvent signal as reference (δ = 7.26 ppm for 1 H NMR). Liquid chromatography -mass spectrometry analysis (LS-MS/MS) was recorded on a Q-Exactive focus instrument. IR spectra were measured on a Spectrum Two Perkin Elmer.
Preparation of compounds 7:
A solution of artemisinin derivative 6 (1 mmol) in ethanol (2 mL) was stirred for 1 h at room temperature. Amine (1mmol) was then added, and the reaction mixture was stirred for 72 h at room temperature. The resulting mixture was quenched with saturated solution of NaHCO 3 and brine. The aqueous phase was then extracted with DCM (3 x 10 mL), dried with Na 2 SO 4 , filtration of the drying agent, and removal of the solvent in vacuo afforded crude products, which was further purified by means of column chromatography on silica gel (using mixture MeOH/DCM as an eluent). Cell culture and cell viability assay: The synthesized compounds7a-7j were evaluated for their cytotoxicity against two human cancer cell lines, including KB and HepG2. Two human cancer cell lines (epidermoid carcinoma cell line (KB) and hepatoma carcinoma cell line (HepG2)), obtained from the American Type Culture Collection (USA) ATCC, were used for cytotoxic evaluation. The cells were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL streptomycin at 37°C in a humidified atmosphere (95% air and 5% CO 2 ). The exponentially growing cells were used throughout the experiments. The inhibitory effects of the compounds on the growth of the human cancer cell lines were determined by measuring the metabolic activity using a 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay [19] . Briefly, human cancer cell lines (3×10 4 cells/mL) were treated for 3 days with a series of concentrations of the compounds (in DMSO): 0.125, 0.5, 2.0, 8.0, 32.0, and 128.0 µg/mL. After incubation, 0.1 mg MTT solution (50 µL of a 2 mg/mL solution) was added to each well, and the cells were then incubated at 37°C for 4 h. The plates were centrifuged at 1000 rpm for 10 min at room temperature, and the media were then carefully aspirated. Dimethylsulfoxide (150 µL) was added to each well to dissolve the formazan crystals. The plates were read immediately at 540 nm on a microplate reader (TECAN GENIOUS). All the experiments were performed three times, and the mean absorbance values were calculated. The results are expressed as the percentage of inhibition that produced a reduction in the absorbance by the treatment of the compounds compared to the untreated controls. A dose-response curve was generated, and the inhibitory concentration of 50% (IC 50 ) was determined for each compound as well as each cell line.
10β-[3ʹ-Methylamino-propan-2ʹ-ol]deoxoartemisinin (7a)

10β-[3ʹ-(4-Methylpiperidinyl)propan-2ʹ-ol]deoxoartemisinin (7h)
Colorless oil.
